E193 E193 (Zonisamide 25 mg)
Pill with imprint E193 E193 is Orange / Gray, Capsule-shape and has been identified as Zonisamide 25 mg. It is supplied by Sandoz Pharmaceuticals Inc..
Zonisamide is used in the treatment of seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E193 E193
Zonisamide
- Imprint:
- E193 E193
- Strength:
- 25 mg
- Color:
- Orange / Gray
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0193
- Inactive Ingredients:
-
- microcrystalline cellulose
- ferrosoferric oxide
- FD&C Red No. 40
- FD&C Yellow No. 6
- gelatin
- hydrogenated castor oil
- sodium lauryl sulfate
- titanium dioxide
Note: Inactive ingredients may vary.
More about zonisamide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 106 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (2)
Consumer resources
Other brands: Zonegran
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
